Matches in Wikidata for { <http://www.wikidata.org/entity/Q92973362> ?p ?o ?g. }
Showing items 1 to 49 of
49
with 100 items per page.
- Q92973362 description "artículu científicu espublizáu en xunu de 2019" @default.
- Q92973362 description "scientific article published on 24 June 2019" @default.
- Q92973362 description "wetenschappelijk artikel" @default.
- Q92973362 description "наукова стаття, опублікована 24 червня 2019" @default.
- Q92973362 name "Phase II trial of continuous treatment with sunitinib in patients with high-risk (BCG-refractory) non-muscle invasive bladder cancer" @default.
- Q92973362 name "Phase II trial of continuous treatment with sunitinib in patients with high-risk (BCG-refractory) non-muscle invasive bladder cancer" @default.
- Q92973362 type Item @default.
- Q92973362 label "Phase II trial of continuous treatment with sunitinib in patients with high-risk (BCG-refractory) non-muscle invasive bladder cancer" @default.
- Q92973362 label "Phase II trial of continuous treatment with sunitinib in patients with high-risk (BCG-refractory) non-muscle invasive bladder cancer" @default.
- Q92973362 prefLabel "Phase II trial of continuous treatment with sunitinib in patients with high-risk (BCG-refractory) non-muscle invasive bladder cancer" @default.
- Q92973362 prefLabel "Phase II trial of continuous treatment with sunitinib in patients with high-risk (BCG-refractory) non-muscle invasive bladder cancer" @default.
- Q92973362 P1433 Q92973362-5D67AD3B-E5A5-4C03-96F0-8F409B9491C9 @default.
- Q92973362 P1476 Q92973362-024BD9CA-B5A3-413B-9193-7B90F6E6E454 @default.
- Q92973362 P2093 Q92973362-06BFEF46-CF3E-4B30-8D0A-B7F3F83D21B0 @default.
- Q92973362 P2093 Q92973362-42E1B978-9E18-4603-80EE-C3272156D91E @default.
- Q92973362 P2093 Q92973362-4ADA7A3F-3C66-4FBD-A6E3-365C5656B628 @default.
- Q92973362 P2093 Q92973362-59496F65-CEE4-4613-BB51-CAAAECEF10E8 @default.
- Q92973362 P2093 Q92973362-78C86F79-B9A9-4D42-88E5-F34D4F960E5C @default.
- Q92973362 P2093 Q92973362-96A0F8B9-E7BB-4B22-BF96-0AECCC449BDB @default.
- Q92973362 P2093 Q92973362-A16390F1-40B9-4E2F-92FC-0284B875EA8C @default.
- Q92973362 P2093 Q92973362-F63C0981-6084-4A3E-853D-AFCF6987AA85 @default.
- Q92973362 P304 Q92973362-5FE5B41B-B93B-477B-ABCA-BF7EAA046F8F @default.
- Q92973362 P31 Q92973362-E3261DB0-40C3-4BF6-984D-B466441F3532 @default.
- Q92973362 P356 Q92973362-29BC850E-65C0-4374-84F9-E1B8A3D402F3 @default.
- Q92973362 P433 Q92973362-E170BCFD-E7E0-482D-B7DF-E3E28E605C92 @default.
- Q92973362 P478 Q92973362-6A3C5143-B1F1-41E9-B1B6-E26A13FEB1AA @default.
- Q92973362 P577 Q92973362-967BD691-375F-441F-A0EE-78B5B042D157 @default.
- Q92973362 P698 Q92973362-A34E76A3-90CB-49C4-B74C-9E325B358C49 @default.
- Q92973362 P921 Q92973362-E52AC57B-4EAE-46F3-BA8E-E0A39A630612 @default.
- Q92973362 P356 S10637-018-00716-W @default.
- Q92973362 P698 31231785 @default.
- Q92973362 P1433 Q2312231 @default.
- Q92973362 P1476 "Phase II trial of continuous treatment with sunitinib in patients with high-risk (BCG-refractory) non-muscle invasive bladder cancer" @default.
- Q92973362 P2093 "Amr Fergany" @default.
- Q92973362 P2093 "Andrew J Stephenson" @default.
- Q92973362 P2093 "Haris Zahoor" @default.
- Q92973362 P2093 "Jorge A Garcia" @default.
- Q92973362 P2093 "Maria C Mir" @default.
- Q92973362 P2093 "Pedro C Barata" @default.
- Q92973362 P2093 "Robert Dreicer" @default.
- Q92973362 P2093 "Steven C Campbell" @default.
- Q92973362 P304 "1231-1238" @default.
- Q92973362 P31 Q13442814 @default.
- Q92973362 P356 "10.1007/S10637-018-00716-W" @default.
- Q92973362 P433 "6" @default.
- Q92973362 P478 "37" @default.
- Q92973362 P577 "2019-06-24T00:00:00Z" @default.
- Q92973362 P698 "31231785" @default.
- Q92973362 P921 Q42824440 @default.